Home » Topics » Infection » HIV/AIDS

HIV/AIDS
RSS

Vical receives HIV vaccine production order to support phase II trials

June 20, 2005

Expanded access program planned for protease inhibitor TMC-114

June 16, 2005

Trimeris, ChemBridge Research Laboratories to develop HIV entry inhibitors

June 16, 2005

Recent patents disclose novel treatments for HIV infection

June 15, 2005

Recent Bayer patent describes new antiretroviral agents

June 8, 2005

IR-103 to be studied in drug naive HIV patients

June 6, 2005

BioInvent set to begin U.K. study of BI-201 for HIV

June 3, 2005

Ranbaxy receives tentative approval for lamivudine tablets

June 1, 2005

CytoGenix licenses DNA plasmid from NIH

May 30, 2005

New Invirase 500 mg formulation approved in Europe

May 30, 2005

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 10, 2026.
Ionis, AZ shares down on unexpected Wainua flop in cardiomyopathy
BioWorld
News of the unexpected phase III failure of the gene silencing drug Wainua (eplontersen) in the treatment of transthyretin-mediated amyloid cardiomyopathy sent...
FENS 2026: Next-gen biologics take on brain disease
BioWorld
Whether by fine-tuning neurotransmitter signaling or silencing disease-associated genes, emerging biologic therapies are reshaping neuroscience drug development,...
Neurovalens granted FDA approval for PTSD therapy for US veterans
BioWorld
Veterans in the U.S. suffering from post-traumatic stress disorder (PTSD) now have access to Neurovalens Ltd.’s Modius Spero, a wearable neuromodulation device,...
NRF2 activators reported in Vailima Peninsula patent
BioWorld Science
Vailima Peninsula Pty Ltd. has discovered new nuclear factor erythroid 2-related factor 2 (NFE2L2; NRF2) activators potentially useful for the treatment of...